Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M413953200 on April 11, 2005

J. Biol. Chem., Vol. 280, Issue 23, 21739-21747, June 10, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/23/21739    most recent
M413953200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pérez, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez, G. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Dual Effect of Tamoxifen on Arterial KCa Channels Does Not Depend on the Presence of the {beta}1 Subunit*

Guillermo J. Pérez{ddagger}

From the Masonic Medical Research Laboratory, Utica, New York 13501

Tamoxifen has been reported to directly activate large conductance calcium-activated potassium (KCa) channels through the KCa {beta}1 subunit, suggesting a cardio-protective role of this compound. The present study using knock-out (KO) mice for the KCa channel {beta}1 subunit was aimed at understanding the molecular mechanisms of the effects of tamoxifen on arterial smooth muscle KCa channels. Single channel studies were conducted in excised patches from cerebral artery myocytes from both wild-type and KO animals. The present data demonstrated that tamoxifen can inhibit arterial KCa channels due to a major decrease in channel open probability (Po), a mechanism different from the reduction in single channel amplitude reported previously and also observed in the present work. A tamoxifen-induced decrease in Po was present in arterial KCa channels from both wild-type and {beta}1 KO animals. This inhibition was concentration-dependent and partially reversible with a half-maximal concentration constant IC50 of 2.6 µM. The effect of tamoxifen was actually dual Single channel kinetic analysis showed that tamoxifen shortens both mean closed time and mean open time; the latter is probably due to an intermediate duration voltage-independent blocking mechanism. Thus, tamoxifen block would predominate when KCa channel Po is >0.1–0.2, limiting the maximum Po, whereas a leftward shift in voltage or Ca2+ activation curves can be observed for Po values lower than those values. This dual effect of tamoxifen appears to be independent of the {beta}1 subunit. The molecular specificity of tamoxifen, or eventually other xenoestrogen derivatives, for the KCa channel {beta}1 subunit is uncertain.


Received for publication, December 13, 2004 , and in revised form, April 8, 2005.

* This work was supported by Grant K01 HL073161-03 from the National Institutes of Health and Grant 0130570T from the American Heart Association, New York affiliate. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Experimental Cardiology, Masonic Medical Research Laboratory, 2150 Bleecker St., Utica, NY 13501. Tel.: 315-735-2217 (ext. 155); Fax: 315-735-5648; E-mail: gperez{at}mmrl.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Tong and R. K. Duncan
Tamoxifen inhibits BK channels in chick cochlea without alterations in voltage-dependent activation
Am J Physiol Cell Physiol, July 1, 2009; 297(1): C75 - C85.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-H. Sun, J.-P. Ding, H. Li, N. Pan, L. Gan, X.-L. Yang, and H.-B. Xu
Activation of Large-Conductance Calcium-Activated Potassium Channels by Puerarin: The Underlying Mechanism of Puerarin-Mediated Vasodilation
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 391 - 397.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. N. Bukiya, J. Liu, L. Toro, and A. M. Dopico
beta1 (KCNMB1) Subunits Mediate Lithocholate Activation of Large-Conductance Ca2+-Activated K+ Channels and Dilation in Small, Resistance-Size Arteries
Mol. Pharmacol., August 1, 2007; 72(2): 359 - 369.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Coiret, A.-S. Borowiec, P. Mariot, H. Ouadid-Ahidouch, and F. Matifat
The Antiestrogen Tamoxifen Activates BK Channels and Stimulates Proliferation of MCF-7 Breast Cancer Cells
Mol. Pharmacol., March 1, 2007; 71(3): 843 - 851.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. N. Krause, S. P. Duckles, and D. A. Pelligrino
Influence of sex steroid hormones on cerebrovascular function
J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement